MT. LAUREL, N.J., Feb. 24 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of technology-enabled clinical documentation services, has introduced the MedQuist Performance Monitor (MPM). The MPM reporting tool provides MedQuist customer facilities with physician, worktype and facility detailed reporting to monitor, track and optimize their clinical reporting process. The MPM offers a value-added benefit for transcription outsourcing customers who use the DocQment® Enterprise Platform, and is robust and relevant enough to meet The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) standards.
As a reporting tool, the MPM produces meaningful, actionable information, including turnaround time (TAT) compliance, worktype and dictator statistics, performance trends, and quality indicators. Key features and benefits include:
For more information on the MedQuist Performance Monitor or to see sample reports, please visit www.medquist.com.
About MedQuist
MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.
"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE MedQuist
Advertisement
As a reporting tool, the MPM produces meaningful, actionable information, including turnaround time (TAT) compliance, worktype and dictator statistics, performance trends, and quality indicators. Key features and benefits include:
Advertisement
- Metrics that can be used to track and manage clinical reporting performance, provide summary reports to management, and obtain data required by The Joint Commission.
- Critical areas tracked:
- TAT compliance -- absolute and average by volume, by worktype and by dictator, and an "early/late" view that is unique in the industry
- Quality Indicator -- "blanks" reporting ratio
- Documentation and author input deficiencies
- Physician performance and compliance
- Measureable, quantifiable data that is displayed in both graph and chart formats for easy interpretation and continuous improvement.
For more information on the MedQuist Performance Monitor or to see sample reports, please visit www.medquist.com.
About MedQuist
MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit www.medquist.com.
"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE MedQuist